References
- Rall T W. Drugs used in the treatment of asthma. The Pharmacologic Basis of Therapeutics, A G Gilman, T W Rall, A S Nies, P Taylor. Pergamon, New York 1990; 618–637
- Zwillich C W, Sutton F D, Neff T A, et al. Theophylline-induced seizures in adults. Correlation with serum concentration. Ann Int Med 1975; 82: 784–787
- Anderson J R, Poklis A, Slavin R G. A fatal case of theophylline intoxication. Arch Intern Med 1983; 143: 559–560
- Covelli H D, Knodel A R, Heppner B T. Predisposing factors to apparent theophylline-induced seizures. Ann Allergy 1985; 54: 411–415
- Greenberg A, Piraino B H, Kroboth P D, Weiss J. Severe theophylline toxicity. Role of conservative measures, antiarrhythmic agents, and charcoal hemoperfusion. Am J Med 1984; 76: 854–860
- Lawyer C, Aitchison J, Sutton J, Bennett W. Treatment of theophylline neurotoxicity with resin hemoperfusion. Ann Intern Med 1978; 88: 516–517
- Sessler C N. Theophylline toxicity: Clinical features of 116 consecutive cases. AmJ Med 1990; 88: 567–576
- Singer E P, Kolischenko A. Seizures due to theophylline overdose. Chest 1985; 87: 755–757
- Yarnell P R, Chu N S. Focal seizures and aminophylline. Neurology 1975; 25: 819–822
- Gaudreault P, Wason S, Lovejoy F H. Acute pediatric theophylline overdose: A summary of 28 cases. J Pediatr 1983; 102: 474–476
- Vaucher Y, Lightner E S, Walson P D. Theophylline poisoning. J Pediatr 1977; 90: 827–830
- Paloucek F P, Rodvold K A. Evaluation of theophylline overdoses and toxicities. Ann Emerg Med 1988; 17: 135–144
- Gaudreault P, Guay J. Theophylline poisoning. Pharmacological considerations and clinical management. Med Toxicol 1986; 1: 169–191
- Goldberg M J, Park G D, Berlinger W G. Treatment of theophylline intoxication. J Allergy Clin Immunol 1986; 78: 811–817
- Dunwiddie T V, Worth T. Sedative and anticonvulsant effects of adenosine analogs in mouse and rat. J Pharmacol Exp Ther 1981; 220: 70–76
- Dragunow M, Goddard G V, Laverty R. Is adenosine an endogenous anticonvulsant?. Epilepsia 1985; 26: 480–487
- Morgan P F, Deckert J, Jacobson K A, Marangos P J, Daly J W. Potent convulsant actions of the adenosine receptor antagonist, xanthine amine congener (XAC). Life Sci 1989; 45: 719–728
- Sawynok J, Sweeney M I. The role of purines in nociception. Neurosclence 1989; 32: 557–569
- Ault B, Olney M A, Joyner J L, et al. Pro-convulsant actions of theophylline and caffeine in the hippocampus: Implications for the management of temporal lobe epilepsy. Brain Res 1987; 426: 93–102
- Czuczwar S J, Kleinrok Z, Turski L, Turski W A. Effect of aminophylline and enprofylline on the protective efficacy of common antiepileptic drugs against electroconvulsions in mice. Epilepsia 1987; 28: 383–386
- Dragunow M, Robertson H A. 8-Cyclopentyl 1,3-dimethylxanthine prolongs epileptic seizures in rats. Brain Res 1987; 417: 377–379
- Litchfield J T, Wilcoxon F. A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 1949; 96: 99
- Londos C, Wolff J. Two distinct adenosine-sensitive sites on adenylate cyclase. Proc Natl Acad Sci USA 1977; 74: 5482–5486
- Marangos P J, Patel J, Smith K D, Post R M. Adenosine antagonist properties of carbamazepine. Epilepsia 1987; 28: 387–394
- Skerritt J H, Davies L P, Johnston G A. Interactions of the anticonvulsant carbamazepine with adenosine receptors. 1. Neurochemical studies. Epilepsia 1983; 24: 634–642
- Skerritt J H, Johnston G AR, Chow S C. Interactions of the anticonvulsant carbamazepine with adenosine receptors. 2. Pharmacological studies. Epilepsia 1983; 24: 643–650
- Weir R L, Padgett W, Daly J W, Anderson S M. Interaction of anticonvulsant drugs with adenosine receptors in the central nervous system. Epilepsia 1984; 25: 492–498
- Weir R L, Anderson S M, Daly J W. Inhibition of N6-[3H]cyclohexyladenosine binding by carbamazepine. Epilepsia 1990; 31: 503–512
- Shannon M W, Maher T. Anticonvulsant efficacy of Adenocard in experimental theophylline-induced seizures. Vet Hum Toxicol 1993; 35: 338